Cardiovascular health and sleep disturbances in two population-based cohort studies

Autor: Pedro Marques-Vidal, Pierre Boutouyrie, José Haba-Rubio, Quentin Lisan, Marie-Cécile Perier, Thomas T. van Sloten, Nicolas Danchin, Jean-Philippe Empana, Raphael Heinzer, Nadine Häusler, Catherine Guibout, Xavier Jouven, Frédérique Thomas
Přispěvatelé: RS: Carim - V01 Vascular complications of diabetes and metabolic syndrome, RS: CARIM - R3.01 - Vascular complications of diabetes and the metabolic syndrome, MUMC+: MA Med Staf Artsass Interne Geneeskunde (9)
Rok vydání: 2019
Předmět:
Blood Glucose
Male
Health Status
Health Behavior
Excessive daytime sleepiness
Disease
Polysomnography
030204 cardiovascular system & hematology
Severity of Illness Index
cardiac risk factors and prevention
DISEASE
Body Mass Index
Cohort Studies
0302 clinical medicine
Epidemiology
Insomnia
030212 general & internal medicine
Prospective cohort study
GENERAL-POPULATION
medicine.diagnostic_test
Smoking
ASSOCIATION
Middle Aged
PREVALENCE
Cholesterol
Aged
Blood Glucose/analysis
Cholesterol/blood
Diet
Exercise
Female
France/epidemiology
Humans
Hypertension/epidemiology
Sleep Wake Disorders/epidemiology
Smoking/epidemiology
Switzerland/epidemiology
epidemiology
Hypertension
France
medicine.symptom
Cardiology and Cardiovascular Medicine
Switzerland
Sleep Wake Disorders
medicine.medical_specialty
Odds
EVENTS
03 medical and health sciences
AGE
Internal medicine
mental disorders
medicine
business.industry
MORTALITY
INSOMNIA
Relative risk
EXCESSIVE DAYTIME SLEEPINESS
business
Zdroj: Heart, 105(19), 1500-1506. BMJ Publishing Group
Heart, vol. 105, no. 19, pp. 1500-1506
ISSN: 1468-201X
1355-6037
DOI: 10.1136/heartjnl-2018-314485
Popis: ObjectiveWe aimed to investigate the association between cardiovascular health (CVH), as defined by the American Heart Association, and several sleep disturbances.MethodsTwo community-based cohorts, the Paris Prospective Study 3 (PPS3, France, n=6441) and the CoLaus study (Switzerland, n=2989) were analysed. CVH includes 7 metrics which all can be classified as poor, intermediate and ideal. Global CVH score was categorised into poor (0–2 ideal metrics), intermediate (3–4 ideal metrics) and ideal (≥5 ideal metrics). Associations between global CVH and self-reported sleep disturbances (proxy of sleep-disordered breathing [SDB], excessive daytime sleepiness, insomnia symptoms and short/long sleep duration) and SDB severity measured by polysomnography (PSG) were investigated. Adjusted OR/relative risk ratio (RRR) and 95% CIs were estimated. Subjects with previous cardiovascular disease were excluded.ResultsCompared with poor CVH, subjects with intermediate and ideal global CVH had lower odds of self-reported SDB in both cohorts (ORs 0.55; 95% CI 0.44 to 0.68 and 0.35; 95% CI 0.22 to 0.53, respectively) and had lower SDB severity measured by PSG (RRR 0.07; 95% CI 0.02 to 0.20) in CoLaus. Subjects with intermediate and ideal global CVH had lower odds of excessive daytime sleepiness in PPS3 (ORs 0.82; 0.72 to 0.95 and 0.80; 0.82 to 1.02, respectively). No consistent associations were found between CVH and sleep duration or insomnia symptoms.ConclusionsHigher levels of CVH are associated with lower odds of SDB and excessive daytime sleepiness. However, causal interpretation cannot be made and associations might be bidirectional.
Databáze: OpenAIRE